Biofrontera Inc. Announces Achievement of Key Milestone in Phase 3 Study of Ameluz®-Photodynamic Therapy (Pdt) in the Treatment of Superficial Basal Cell Carcinoma (Sbcc)
Biofrontera Inc. 宣布在 Ameluz® 光动力疗法 (Pdt) 治疗表浅性基底细胞癌 (Sbcc) 第三阶段研究中取得关键里程碑
Biofrontera Inc. Announces Achievement of Key Milestone in Phase 3 Study of Ameluz®-Photodynamic Therapy (Pdt) in the Treatment of Superficial Basal Cell Carcinoma (Sbcc)
Biofrontera Inc. 宣布在 Ameluz® 光动力疗法 (Pdt) 治疗表浅性基底细胞癌 (Sbcc) 第三阶段研究中取得关键里程碑
使用浏览器的分享功能,分享给你的好友吧